cardiovascular benefits of semaglutide 🫀 SELECT: Semaglutide's Rapid (data from #ECO2025) 🔹In adults with obesity & established CVD (no diabetes), 2.4 mg weekly: 🔸⤵️ MACE by 41% within 6 months 🔹🕒 First significant Semaglutide: A Game-Changer In Managing

Yan Y, Liu B, Du J et al (2021) SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis

Ozempic and Mounjaro , for example, are often highlighted in discussions about effective diabetes and weight management treatments

For some reason, there is a possibility that it does cause UTI

Ball jar in one go, Kitchens says

Loren Pickart's original 1973 identification of GHK characterized it as a factor in human plasma responsible for restoring proliferation to liver cells in cultures supplemented with older-donor plasma

Conclusion In this data sampling of German inpatients, more than one-third of ASCVD patients may qualify for GLP-1 RA therapy due to concomitant diabetes mellitus or obesity